Targacept, Inc.
0 followers
‌
Targacept is developing a diverse pipeline of innovative NNR Therapeuticsâ„¢ for difficult-to-treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulate the activity of specific neuronal nicotinic receptors, unique proteins that regulate vital biological functions that... Read more
Industries
Headquarters
Employees
Links
Org chart
Stephen A. Hill
President and Chief Executive Officer
Stephen A. Hill
Collapse
Jeff Brennan
Chief Business Officer Sr Vice President Business Commerical Development
Merouane Bencherif
Senior Vice President
Ronald Heemstra
Scientist III
